Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-29IMRN3Immuron Ltd CFO Aaron Laurita Form 3 Filing - No Securities Owned
This is a Form 3 filing by Aaron James Laurita, Chief Financial Officer of Immuron Ltd (ticker: IMRN). The filing reports that as of February 9, 2026, Laurita owns no securities in the company. The filing was signed on April 29, 2026, and indicates Laurita's position as CFO but not as a director or 10% owner. The addre...
Nano CapBiotechnology
2026-04-29IMRN3Initial Statement of Beneficial OwnershipMEDIUM
This filing reports the initial statement of beneficial ownership for Steven George Lydeamore, Chief Executive Officer of Immuron Ltd. As of March 18, 2026, Mr. Lydeamore directly owns 3,155,047 ordinary shares. The filing also details derivative holdings, including 1,430,000 options with an exercise price of $0.0861 a...
Nano CapBiotechnology
2026-04-29OLMA3Power of Attorney for Prakash Raman
This filing documents a Power of Attorney granted by Prakash Raman, a director at Olema Pharmaceuticals, Inc., to Amoli Pandya, Sean Bohen, and Shawnte Mitchell. The attorneys-in-fact are authorized to prepare, execute, and file SEC Forms 3, 4, and 5 on behalf of Mr. Raman, as required by Section 16(a) of the Securitie...
Small CapBiotechnology
2026-04-29IMUX3Power of Attorney for Michael A. Panzara
This filing documents a Power of Attorney granted by Michael A. Panzara to Ilan Katz, Grant Levine, Zach Weiss, Madeline Hunter, and Margaux Bouchet of Dentons US LLP. The attorneys-in-fact are authorized to manage Panzara's EDGAR account, prepare and submit various securities filings with the SEC, including Forms 3, 4...
Micro CapBiotechnology
2026-04-29Olema Pharmaceuticals, Inc.3Power of Attorney for Prakash RamanDuplicate
This filing documents a Power of Attorney granted by Prakash Raman, a director at Olema Pharmaceuticals, Inc., to Amoli Pandya, Sean Bohen, and Shawnte Mitchell. The attorneys-in-fact are authorized to prepare, execute, and file SEC Forms 3, 4, and 5 on behalf of Mr. Raman, as required by Section 16(a) of the Securitie...
Small CapBiotechnology
2026-04-29IMRN3Immuron Ltd. - Form 3 FilingMEDIUM
This filing details changes in beneficial ownership for Immuron Ltd. (IMRN). Ravi Savarirayan, a director, acquired options to purchase 1,000,000 ordinary shares with an exercise price of $0.0789 and 333,333 ordinary shares with an exercise price of $0.1040. These options have various vesting and expiration dates in 20...
Nano CapBiotechnology
2026-04-28ARMP3Armata Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership
This filing is an initial statement of beneficial ownership for Daniel B. Gilmer, reporting owner and director at Armata Pharmaceuticals, Inc. The filing, dated April 28, 2026, pertains to the period of report ending April 24, 2026. It indicates that Mr. Gilmer does not beneficially own any securities of the company as...
Small CapBiotechnology
Sponsored